Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kristine Doney

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Concepts & Ideas

Living Beings

Infant

Anatomy

T-Lymphocytes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kristine Doney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2008: Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
2007: Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: Doney Kristine; Hägglund Hans; Leisenring Wendy; Chauncey Thomas; Appelbaum Frederick R; Storb Rainer
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):472-81.
2003: Stirewalt Derek L; Guthrie Katherine A; Beppu Lan; Bryant Eileen M; Doney Kris; Gooley Ted; Appelbaum Frederick R; Radich Jerald P
Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):206-12.
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Platzbecker Uwe; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Clurman Bruce; Doney Kris; Chauncey Thomas; Flowers Mary E D; Myerson David; Radich Jerald P; Storb Rainer; Witherspoon Robert P; Deeg H Joachim
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Masood Nehal; Russell Kenneth J; Olerud John E; Sabath Daniel E; Sale George E; Doney Kristine C; Flowers Mary E D; Fefer Alexander; Thompson John A
Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation.
Journal of the American Academy of Dermatology 2002;47(1):140-5.
2002: Doney K C; Chauncey T; Appelbaum F R;
Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
Bone marrow transplantation 2002;29(10):817-23.
2002: Carpenter Paul A; Appelbaum Frederick R; Corey Lawrence; Deeg H Joachim; Doney Kris; Gooley Theodore; Krueger James; Martin Paul; Pavlovic Sandra; Sanders Jean; Slattery John; Levitt Daniel; Storb Rainer; Woolfrey Ann; Anasetti Claudio
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Woolfrey Ann E; Anasetti Claudio; Storer Barry; Doney Kristine; Milner Laurie A; Sievers Eric L; Carpenter Paul; Martin Paul; Petersdorf Effie; Appelbaum Frederick R; Hansen John A; Sanders Jean E
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
Blood 2002;99(6):2002-8.
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: Torok-Storb B; Bolles L; Iwata M; Doney K; Sale G E; Gooley T A; Storb R
Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia.
Blood 2001;98(3):891-2.
2001: Storb R; Blume K G; O'Donnell M R; Chauncey T; Forman S J; Deeg H J; Hu W W; Appelbaum F R; Doney K; Flowers M E; Sanders J; Leisenring W
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2000: Furlong T; Storb R; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K; Witherspoon R; Nash R A
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
1997: Deeg H J; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum F R; Chauncey T R; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan K M; Witherspoon R P; Storb R
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Doney K; Leisenring W; Storb R; Appelbaum F R
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Annals of internal medicine 1997;126(2):107-15.
1996: Kiem H P; McDonald G B; Myerson D; Spurgeon C L; Deeg H J; Sanders J E; Doney K; Appelbaum F R; Sullivan K M; Witherspoon R P; Storb R
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):93-9.
1996: Sanders J E; Hawley J; Levy W; Gooley T; Buckner C D; Deeg H J; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum F R
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: Flowers M E; Zanis J; Pasquini R; Deeg H J; Ribeiro R; Longton G; Medeiros C R; Doney K; Sanders J; Bryant J
Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation.
British journal of haematology 1996;92(3):699-706.
1996: Wagner J L; Deeg H J; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan K M; Storb R
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
Transplantation 1996;61(1):54-61.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1995: Doney K C; Storb R; Beach K; Anasetti C; Deeg H J; Hansen J A; Martin P J; Nash R A; Schubert M M; Sullivan K M
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Transplantation 1995;60(1):55-8.
1995: Demirer T; Petersen F B; Appelbaum F R; Barnett T A; Sanders J; Deeg H J; Storb R; Doney K; Bensinger W I; Shannon-Dorcy K
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
1995: Nash R A; Etzioni R; Storb R; Furlong T; Gooley T; Anasetti C; Appelbaum F R; Doney K; Martin P; Slattery J
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Blood 1995;85(12):3746-53.
1994: Weaver C H; Clift R A; Deeg H J; Storb R; Appelbaum F R; Bensinger W; Doney K; Hansen J A; Martin P O; Sanders J
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
1994: Clift R A; Buckner C D; Thomas E D; Bryant E; Anasetti C; Bensinger W I; Bowden R; Deeg H J; Doney K C; Fisher L D
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
Blood 1994;84(12):4368-73.
1994: Clift R A; Buckner C D; Thomas E D; Bensinger W I; Bowden R; Bryant E; Deeg H J; Doney K C; Fisher L D; Hansen J A
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
Blood 1994;84(6):2036-43.
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Busca A; Anasetti C; Anderson G; Appelbaum F R; Buckner C D; Doney K; Martin P J; Petersdorf E; Sanders J E; Hansen J A
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
1994: Storb R; Leisenring W; Deeg H J; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Doney K; Hansen J
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Blood 1994;83(9):2749-50.
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Doney K; Storb R; Appelbaum F R; Buckner C D; Sanders J; Singer J; Hansen J A
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
British journal of haematology 1993;85(1):182-4.
1993: Anderson J E; Appelbaum F R; Fisher L D; Schoch G; Shulman H; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Doney K
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Petersen F B; Lynch M H; Clift R A; Appelbaum F R; Sanders J E; Bensinger W I; Benyunes M C; Doney K; Fefer A; Martin P
Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1353-60.
1993: Greinix H T; Storb R; Sanders J E; Deeg H J; Doney K C; Sullivan K M; Witherspoon R P
Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).
British journal of haematology 1993;84(3):515-20.
1992: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Davis J; Doney K; Hill H F; Stewart P; Sullivan K M
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
1992: Nash R A; Pepe M S; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum F R; Bowden R A; Deeg H J; Doney K
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Storb R; Pepe M; Deeg H J; Anasetti C; Appelbaum F R; Bensinger W; Buckner C D; Cliff R A; Doney K; Hansen J
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Blood 1992;80(2):560-1.
1992: Doney K; Pepe M; Storb R; Bryant E; Anasetti C; Appelbaum F R; Buckner C D; Sanders J; Singer J; Sullivan K
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Flowers M E; Doney K C; Storb R; Deeg H J; Sanders J E; Sullivan K M; Bryant E; Witherspoon R P; Appelbaum F R; Buckner C D
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
British journal of haematology 1992;80(1):49-54.
1992: Buckner C D; Doney K; Sanders J; Petersen F; Appelbaum F
Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():193-5.
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Calori E; Davis J; Doney K; Reichert T; Stewart P
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
1990: Clift R A; Buckner C D; Appelbaum F R; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I; Doney K
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
1990: Martin P J; Schoch G; Fisher L; Byers V; Anasetti C; Appelbaum F R; Beatty P G; Doney K; McDonald G B; Sanders J E
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Blood 1990;76(8):1464-72.
1990: Storb R; Pepe M; Anasetti C; Appelbaum F R; Beatty P; Doney K; Martin P; Stewart P; Sullivan K M; Witherspoon R
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Blood 1990;76(5):1037-45.
1990: Storb R; Appelbaum F; Buckner C D; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Flowers M E; Pepe M S; Longton G; Doney K C; Monroe D; Witherspoon R P; Sullivan K M; Storb R
Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation.
British journal of haematology 1990;74(4):492-6.
1990: Storb R; Buckner C D; Clift R A; Appelbaum F R; Doney K C; Martin P; Anasetti C; Hansen J; Sanders J E; Petersen F B
Marrow grafting for acute leukemia: results and future treatment strategies.
Haematology and blood transfusion 1990;33():629-35.
1989: Sanders J; Sullivan K; Witherspoon R; Doney K; Anasetti C; Beatty P; Petersen F B
Long term effects and quality of life in children and adults after marrow transplantation.
Bone marrow transplantation 1989;4 Suppl 4():27-9.
1989: Witherspoon R P; Fisher L D; Schoch G; Martin P; Sullivan K M; Sanders J; Deeg H J; Doney K; Thomas D; Storb R
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
The New England journal of medicine 1989;321(12):784-9.
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
1989: Sullivan K M; Buckner C D; Sanders J E; Anasetti C; Appelbaum F R; Clark J; Doney K; Meyers J; Sale G; Storb R
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1988: Martin P J; Clift R A; Fisher L D; Buckner C D; Hansen J A; Appelbaum F R; Doney K C; Sullivan K M; Witherspoon R P; Storb R
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
1988: Witherspoon R P; Sullivan K M; Lum L G; Goehle S; Atkinson M K; Ochs H D; Doney K C; Hansen J A; Sanders J E; Storb R
Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up.
Bone marrow transplantation 1988;3(5):425-35.
1988: Lum L G; Noges J E; Beatty P; Martin P J; Deeg J; Doney K C; Loughran T; Sullivan K M; Witherspoon R P; Thomas E D
Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.
Bone marrow transplantation 1988;3(5):399-406.
1988: Sullivan K M; Witherspoon R P; Storb R; Deeg H J; Dahlberg S; Sanders J E; Appelbaum F R; Doney K C; Weiden P; Anasetti C
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1988: Sullivan K M; Witherspoon R P; Storb R; Weiden P; Flournoy N; Dahlberg S; Deeg H J; Sanders J E; Doney K C; Appelbaum F R
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood 1988;72(2):546-54.
1988: Sanders J E; Buckner C D; Amos D; Levy W; Appelbaum F R; Doney K; Storb R; Sullivan K M; Witherspoon R P; Thomas E D
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):813-8.
1988: Doney K; Storb R; Buckner C D; Thomas E D
Treatment of gold-induced aplastic anaemia with immunosuppressive therapy.
British journal of haematology 1988;68(4):469-72.
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Sanders J E; Buckner C D; Clift R A; Fefer A; McGuffin R; Storb R; Appelbaum F; Bensinger W; Beatty P; Doney K
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
1988: Sanders J E; Buckner C D; Sullivan K M; Doney K; Appelbaum F; Witherspoon R; Storb R; Thomas E D
Growth and development in children after bone marrow transplantation.
Hormone research 1988;30(2-3):92-7.
1987: Doney K; Buckner C D; Kopecky K J; Sanders J E; Appelbaum F R; Clift R; Sullivan K; Witherspoon R; Storb R; Thomas E D
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
Bone marrow transplantation 1987;2(4):355-63.
1987: Appelbaum F R; Barrall J; Storb R; Ramberg R; Doney K; Sale G E; Thomas E D
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.
Experimental hematology 1987;15(11):1134-9.
1987: Meyers J D; Flournoy N; Sanders J E; McGuffin R W; Newton B A; Fisher L D; Lum L G; Appelbaum F R; Doney K; Sullivan K M
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
Annals of internal medicine 1987;107(6):809-16.
1987: Lum L G; Seigneuret M C; Doney K C; Storb R
In vitro immunoglobulin production, proliferation, and cell markers before and after antithymocyte globulin therapy in patients with aplastic anemia.
American journal of hematology 1987;26(1):1-15.
1987: Storb R; Weiden P L; Sullivan K M; Appelbaum F R; Beatty P; Buckner C D; Clift R A; Doney K C; Hansen J; Martin P J
Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Blood 1987;70(1):116-21.
1987: Kanfer E J; Buckner C D; Fefer A; Storb R; Appelbaum F R; Hill R S; Amos D; Doney K C; Clift R A; Shulman H M
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Bone marrow transplantation 1987;1(4):339-46.
1987: Doney K; Storb R; Buckner C D; McGuffin R; Witherspoon R; Deeg H J; Appelbaum F R; Sullivan K M; Thomas E D
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: Storb R; Deeg H J; Whitehead J; Farewell V; Appelbaum F R; Beatty P; Bensinger W; Buckner C D; Clift R A; Doney K
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Transplantation proceedings 1987;19(1 Pt 3):2608-13.
1987: Kanfer E J; Petersen F B; Buckner C D; Stewart P; Storb R; Hill R S; Appelbaum F R; Clift R A; Doney K C; Shulman H M
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Cancer treatment reports 1987;71(1):101-2.
1986: Deeg H J; Sullivan K M; Buckner C D; Storb R; Appelbaum F R; Clift R A; Doney K; Sanders J E; Witherspoon R P; Thomas E D
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Sanders J E; Pritchard S; Mahoney P; Amos D; Buckner C D; Witherspoon R P; Deeg H J; Doney K C; Sullivan K M; Appelbaum F R
Growth and development following marrow transplantation for leukemia.
Blood 1986;68(5):1129-35.
1986: Bolger G B; Sullivan K M; Spence A M; Appelbaum F R; Johnston R; Sanders J E; Deeg H J; Witherspoon R P; Doney K C; Nims J
Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease.
Neurology 1986;36(8):1087-91.
1986: Storb R; Deeg H J; Farewell V; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.
Blood 1986;68(1):119-25.
1986: Bolger G B; Sullivan K M; Storb R; Witherspoon R P; Weiden P L; Stewart P; Sanders J; Meyers J D; Martin P J; Doney K C
Second marrow infusion for poor graft function after allogeneic marrow transplantation.
Bone marrow transplantation 1986;1(1):21-30.
1986: Storb R; Deeg H J; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Doney K; Farewell V
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
The New England journal of medicine 1986;314(12):729-35.
1986: Hill R S; Petersen F B; Storb R; Appelbaum F R; Doney K; Dahlberg S; Ramberg R; Thomas E D
Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
Blood 1986;67(3):811-6.
1985: Storb R; Deeg H J; Thomas E D; Appelbaum F R; Buckner C D; Cheever M A; Clift R A; Doney K C; Flournoy N; Kennedy M S
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: Torok-Storb B; Doney K; Sale G; Thomas E D; Storb R
Subsets of patients with aplastic anemia identified by flow microfluorometry.
The New England journal of medicine 1985;312(16):1015-22.
1985: Irle C; Deeg H J; Buckner C D; Kennedy M; Clift R; Storb R; Appelbaum F R; Beatty P; Bensinger W; Doney K
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Leukemia research 1985;9(10):1255-61.
1984: Doney K C; Torok-Storb B; Dahlberg S; Buckner C D; Martin P; Hansen J A; Thomas E D; Storb R
Immunosuppressive therapy of severe aplastic anemia.
Progress in clinical and biological research 1984;148():259-70.
1983: Storb R; Prentice R L; Sullivan K M; Shulman H M; Deeg H J; Doney K C; Buckner C D; Clift R A; Witherspoon R P; Appelbaum F A; Sanders J E; Stewart P S; Thomas E D
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.
Annals of internal medicine 1983;98(4):461-6.
1982: Storb R; Doney K C; Thomas E D; Appelbaum F; Buckner C D; Clift R A; Deeg H J; Goodell B W; Hackman R; Hansen J A; Sanders J; Sullivan K; Weiden P L; Witherspoon R P
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.
Blood 1982;59(2):236-46.
1981: Doney K C; Weiden P L; Buckner C D; Storb R; Thomas E D
Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow.
Experimental hematology 1981;9(8):829-34.
1981: Doney K C; Weiden P L; Storb R; Thomas E D
Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients.
Transplantation 1981;31(2):141-3.
1981: Doney K C; Weiden P L; Storb R; Thomas E D
Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
American journal of hematology 1981;11(1):1-8.
1980: Shulman H M; McDonald G B; Matthews D; Doney K C; Kopecky K J; Gauvreau J M; Thomas E D
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.
Gastroenterology 1980;79(6):1178-91.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Kristine Doney

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Phenomena

Concepts & Ideas

Living Beings

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Kristine Doney (preview)

All Publications